Fenretinide targeting of human colon cancer sphere cells through cell cycle regulation and stress‑responsive activities
- 13 August 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (4) , 5339-5348
Abstract
Cancer stem cells (CSCs) are considered to be the main cause of chemoresistance and the resultant low survival rate of patients with cancer. N‑(4‑hydroxyphenyl)‑retinamide, known as fenretinide or 4HPR, is a synthetic derivative of all‑trans‑retinoic acid. It is a promising anticancer agent, has minimal side effects and synergizes with other anticancer agents to reinforce their anticancer efficacy. The present study investigated whether fenretinide eliminated colon sphere cells. HT29 and HCT116 cells incubated in low‑serum culture medium were more sensitive to fenretinide treatment than those incubated in full‑serum medium. Colon spheres formed in serum‑free medium demonstrated stem‑like characteristics. The percentage of cluster of differentiation (CD) 44+ cells was significantly higher in sphere cells compared with parental cells. Sphere cells also demonstrated increased tumorigenic ability in non‑obese diabetic/severe combined immunodeficiency mice. Fenretinide inhibited the formation of colon spheres in HT29 and HCT116 cells. Microarray, cell cycle and reverse transcription‑quantitative polymerase chain reaction analysis revealed that fenretinide induced genes associated with cell cycle regulation and the stress response in fenretinide‑treated HT29 sphere cells. To the best of our knowledge, the present study was the first to investigate the effect of fenretinide on colon stem cells. Fenretinide was demonstrated to preferentially target colon sphere cells, which may possess certain stem‑like characteristics. These results are an important addition to the current knowledge concerning fenretinide, and provide a foundation for its clinical application in the treatment of cancer.Keywords
This publication has 38 references indexed in Scilit:
- Understanding cancer stem cell heterogeneity and plasticityCell Research, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Converting Redox Signaling to Apoptotic Activities by Stress-Responsive Regulators HSF1 and NRF2 in Fenretinide Treated Cancer CellsPLOS ONE, 2009
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- Cancer Stem Cell–Directed Therapies: Recent Data From the Laboratory and ClinicMolecular Therapy, 2009
- The Gene Ontology project in 2008Nucleic Acids Research, 2007
- Mediators of endoplasmic reticulum stress‐induced apoptosisEMBO Reports, 2006
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001